Observational studyViruses2023

Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study.

Cristina Mussini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.